You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Greece

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Despite the recession consumer health grows in 2011

Consumer health recorded a slight increase in value during 2011 in spite the rapid deterioration of the Greek economy and the devastating effects of this economic decline on disposable income levels. The long-anticipated categorisation of OTC drugs in 2010 set a clear framework for consumer health products in Greece, with positive effects remaining visible in 2011 after the confusion and uncertainty which characterised 2010. Important price increases imposed under the new mandatory price list published in August 2011 boosted value growth in consumer health, while the wave of switches which occurred in early 2011 was also a significant factor in value growth during 2011 as new products and categories were included within OTC consumer health. Moreover, the ongoing rise of the health and wellness trend favoured the development of vitamins and dietary supplements, while the emerging self-medication trend as Greek consumers supplanted expensive visits to the doctor with self-medication on the recommendations of pharmacists worked in favour of OTC consumer health.

Price increases, switches and the ‘negative’ list change the shape of consumer health

The wave of switches which occurred during early 2011 was a very important development for consumer health due to the reclassification of entire categories such as NRT inhalators as OTC drugs. Price increases have also has a very significant impact as the prices previously charged for OTC products in Greece were very low compared to other EU countries. These increases have been welcomed by Greece’s consumer health industry, although the leading players in consumer health continue to push for the liberation of prices from state control—a longstanding demand, which is now more likely than ever to be fulfilled in the near future. Moreover, the publication in 2011 of a ‘negative’ or ‘grey’ list, which comprises prescription-bound but non-reimbursable drugs, is a very important development as industry officials believe that many of the products included on this negative list are products which are prime candidates for a future switch to OTC.

No significant changes among leading consumer health players in 2011

During 2011, consumer health in Greece continued to be led by established brands and players such as Novartis (Hellas) SACI and Power Health Hellas SA. Most of the brands within consumer health in Greece are longstanding and highly trusted names as Greeks seem less inclined to experiment when it comes to healthcare products. This naturally led to minimal fluctuation in terms of value shares as consumers predominantly remained loyal to the brands which they find most effective or those which they have simply become accustomed to purchasing.

Chemists/pharmacies dominate value sales in consumer health

Chemists/pharmacies remained the dominant distribution channel for consumer health in Greece during 2011. In many cases, chemists/pharmacies remained the only distribution channel for certain consumer health products in Greece. Greek law clearly dictates that OTC drugs must be sold exclusively through chemists/pharmacies and this played a major role in preserving the position of chemists/pharmacies. The operators of Greece’s chemists/pharmacies outlets are increasingly focusing on cooperating with consumer health manufacturers, many of which rely heavily on in-store promotions and the recommendations of pharmacists to generate sales. It is generally admitted that amidst the severe economic recession and the concomitant decline in visits to doctors due to shrinking disposable incomes, the role of the chemists and pharmacists has been upgraded. At the same time, the number of e-pharmacies in Greece constantly grows, with the proportion of total consumer health value sales accounted for by e-sales increasing ion 2011, especially in categories such as vitamins and dietary supplements.

Future performance relies on switches and price liberation

The future performance of consumer health in Greece will depend greatly on two basic factors: switches and price liberation. A new wave of switches is anticipated during the forecast period, especially with regards to products which were included in the recently published ‘negative’ list, although a new wave of switches will be a timely and costly procedure. Nevertheless, a new round of switches will eventually lead to significant developments and high growth in sales and advertising budgets. Important developments and high growth are expected to result from the liberation of the prices charged for consumer health products from state control, a move which has long been demanded by key industry players and one which seems to be more likely to occur by the day.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Greece with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Greece, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Greece for free:

The Consumer Health in Greece market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Greece?
  • What are the major brands in Greece?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Greece - Industry Overview

EXECUTIVE SUMMARY

Despite the recession consumer health grows in 2011

Price increases, switches and the ‘negative’ list change the shape of consumer health

No significant changes among leading consumer health players in 2011

Chemists/pharmacies dominate value sales in consumer health

Future performance relies on switches and price liberation

KEY TRENDS AND DEVELOPMENTS

Price increases trigger wave of switches and subsequent growth in consumer health

Recession leads to growing price awareness, yet quality remains decisive factor in many consumer health categories

Shrinking disposable income increases levels of self- medication

Focused positioning and clear benefits rewarded by consumers

Shrinking disposable income slows down momentum of herbal/traditional products

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Greece - Company Profiles

Adelco SA in Consumer Health (Greece)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

ApiVita SA in Consumer Health (Greece)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Summary ApiVita SA: Competitive Position 2011

Korres Natural Products SA in Consumer Health (Greece)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Korres Natural Products SA: Competitive Position 2011

Sarantis SA in Consumer Health (Greece)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Sarantis SA: Competitive Position 2011

Uni-Pharma SA in Consumer Health (Greece)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Uni-Pharma SA: Competitive Position 2011

Adult Mouth Care in Greece - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care declined in value by 3% during 2011 as the category was hit by the ongoing economic crisis and shrinking disposable incomes in Greece. The products categorised under adult mouth care are widely considered to be non-essential purchases by the majority of Greeks and therefore financially strained consumers abandoned the category in 2011 as expenditure on non-essential products was curtailed. Furthermore, shrinking disposable incomes may have also forced many Greek consumers to pay fewer visits to the dentist, in most cases the person who advises on the use of adult mouth care. In addition, during 2011 there was a clear shift towards alcohol-free variants in adult mouth care in Greece.

COMPETITIVE LANDSCAPE

  • Adult mouth care in Greece remains focused around a handful of leading brands and companies. Janssen-Cilag Pharmaceutical continued to lead the category in 2011, mainly due to the popularity of its leading brand Hexalen, which accounted for 42% of total adult mouth care retail value sales in 2011. Hexalen has become the most recognised brand in adult mouth care in Greece largely due to the fact that it is very commonly recommended by doctors and dentists, whilst Greek consumers appreciate the relief it offers from the discomfort caused by a variety of mouth ailments.

PROSPECTS

  • As the already adverse economic situation in Greece is expected to deteriorate over the forecast period, Greek consumers are set to see their incomes shrink even further. In this context, intense promotions and price competition can be expected in adult mouth care, and this will result in more slender profit margins for the chemists/pharmacies which are the main retail distributors of adult mouth care in Greece.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Greece - Category Analysis

HEADLINES

TRENDS

  • Despite the general economic gloom which prevails in Greece, analgesics recorded positive growth during 2011. While no significant developments took place in analgesics in 2011 with respect to innovation and new product launches, demand for analgesics continues to rise due to the increasing trend towards self-medication in Greece. Many Greek people are either unwilling or unable to pay for a visit to the doctor when suffering from a minor illness such as flu, colds or headaches, choosing instead to take analgesics with which they are familiar. Popular choices include Depon and Panadol, although any analgesics which have been recommended by pharmacists will generally be acceptable to Greek people. Ibuprofen continued to record strong growth in 2011, while there is increasing demand for stronger and more effective analgesics sold under brands such as Panadol Extra and Depon Maximum.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bristol-Myers Squibb SA continued to lead analgesics in Greece during 2011 with an 18% value share. The company’s leadership can be attributed to its popular brand Depon, which remained the leading brand in acetaminophen in 2011. Depon has achieved widespread recognition in Greece and has been present in the category for a long time. Bristol-Myers Squibb maintained innovation during 2011 by broadening the range of products on offer in terms of format, packaging and dosage. Depon Maximum performed particularly well in Greece during 2011.

PROSPECTS

  • The prevailing consumer trends in 2011 revealed a preference for stronger analgesics as these are generally more effective and offer more rapid pain relief than standard analgesics. The leading manufacturers of analgesics in Greece responded by investing in the development and promotion of stronger analgesics, with the majority of their advertising budgets spent on promoting ‘maximum strength’ and ‘extra strength’ variants. Therefore, these stronger analgesics are expected to be the main drivers of growth in analgesics in Greece during the forecast period. In a similar vein, ibuprofen will also continue growing in importance over the forecast period. The ongoing segmentation of analgesics in Greece into a category of products which offer specific pain relief will also play an important role during the forecast period by streamlining the product selection process. In the case of topical analgesics, in line with the increasing demand for convenience in Greece, the proportion of products in the category in cream/gel format is expected to continue increasing over the forecast period, at the expense of patches.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Greece - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping in Greece increases in value by 8% in 2011, with total retail value sales remaining on €3 million. Rapidly rising stress levels and the much higher incidence of insomnia amidst Greece’s severe economic downturn have led increasing numbers of Greek consumers to turn to calming and sleeping products. The use of calming and sleeping products in Greece was previously associated with the accelerating pace of life of the average Greek consumer. However, since 2009, the use of calming and sleeping products has mostly been linked with economic uncertainty and heavy financial burdens and stress and insomnia have come to affect an ever-increasing proportion of the Greek population. However, it must also be noted that Greek consumers increasingly prefer products which help them cope with stress, but without causing drowsiness or leading to dependency and addiction.

COMPETITIVE LANDSCAPE

  • The range of companies and brands operating in calming and sleeping products in Greece remained minimal in 2011, with no changes recorded from 2010, apart from the discontinuation of the Songha Night brand by Boehringer Ingelheim. The leading player in calming and sleeping in Greece during 2011 was Sarantis SA with its Quiet Life brand. Quiet Life enjoys a high level of brand awareness amongst Greeks, which helped Sarantis SA to secure a retail value share of 48% in 2011.

PROSPECTS

  • Calming and sleeping in Greece is expected to continue registering positive growth during the forecast period, increasing in constant value at a CAGR of 5%. Economic recession and rising levels of unemployment in Greece will inevitably result in an increase in the incidence of stress and insomnia among Greek consumers during the forecast period. In addition, the increasing pace of everyday life in Greece is not expected to slow down or stall during the forecast period, resulting in an increase in demand for calming and sleeping products. As Greek consumers are slowly overcoming the taboos which were previously attached to the use of calming and sleeping products, the penetration of the category continues to increase.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Greece - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies is a mature category in Greece and there is little room for development or innovation. No specific trends characterised the category during 2011 as demand is largely dependent on weather conditions and the incidence of illness. In this respect, 2011 was a good year for cough, cold and allergy (hay fever) remedies, which continues to face significant competition from Rx drugs as the majority of Greeks would prefer to see a doctor when faced with these types of ailments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Medicated confectionery is one of the few categories in consumer health in Greece in which products are mainly distributed through grocery retailers and street kiosks. As a result of this, the products categorised under medicated confectionery are extremely easy to find and, in addition, medicated confectionery is seldom perceived as being pharmaceutical products among Greece consumers. The leading player in medicated confectionery in Greece, Cadbury Hellas, held a 31% value share in cough, cold and allergy (hay fever) remedies in Greece in 2011. No significant changes occurred in the company rankings competitive environment in cough, cold and allergy (hay fever) remedies in Greece during 2011.

PROSPECTS

  • The current legislative environment in Greece—according to which OTC products can be advertised but their prices remain under state control—does not allow for significant developments in cough, cold and allergy (hay fever) remedies. In this Rx-driven category, the potential liberation of prices form state control—a development which has been highly anticipated by industry officials—would pave the way for switches and new product developments, which would drive value growth. The inclusion of leading cough remedies brands such as Mucothiol, Sinecod and Mucosolvan as well as the Comtrex Cold combination products - cough, cold and allergy (hay fever) remedies brand on the so-called ‘negative’ list published in May 2011 represents a very significant development. These products remain under prescription-only status, but the cost of these medicines is no longer reimbursed by the Greek State. Industry officials estimate that is the first step towards these products being switched to OTC status. However, it will be necessary for certain procedures to be performed before this occurs, and it is uncertain whether the switching of these products will occur within the forecast period. Nevertheless, the switch of these brands to OTC status would likely lead to them being intensely advertised and promoted and this would in turn result in significant value growth in cough, cold and allergy remedies.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Greece - Category Analysis

HEADLINES

TRENDS

  • The severe economic recession which prevails in Greece and the publication of the so-called ‘negative’ list of non-reimbursable prescription-only drugs in May 2011 are the two events which continue to have the most significant effect on value sales of digestive remedies. Shrinking disposable income levels pushed Greek consumers to turn to reimbursable prescription-only Rx antacids. Meanwhile the cessation of reimbursement for prescription-only laxatives, which were included in the so-called ‘negative’ or ‘grey’ list published in May 2011, boosted value sales growth for OTC laxatives in 2012 which were already non-reimbursable. In general terms, the pace of life in Greece increased rapidly over the course of the review period and as a result of this many more Greek consumers have found themselves with less time to prepare meals of a decent quality. As a result, the diets of contemporary Greek consumers now contain higher levels of fat, sugar and processed ingredients, all of which contribute to digestive problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis SA remained the leading company in digestive remedies in Greece during 2011 with a retail value share of 27%. The company’s strong position is due to its popular Maalox brand in antacids, which enjoys high levels of recognition and trust amongst Greek consumers and is often used as a byword for antacids in Greece.

PROSPECTS

  • Very significant developments occurred in OTC consumer health in Greece during 2011 and these developments are set to change the image of OTC digestive remedies in Greece during the forecast period. The inclusion of Rx laxatives on the so-called ‘negative’ or ‘grey’ list of non-reimbursable prescription-only drugs which was published during May 2011 is considered by industry officials as the first step towards the switch of these drugs to OTC status. While many prescription-only laxatives are considered as prime candidates for a future switch to OTC status, there is little agreement on when this will eventuate as there are several time-consuming procedures which will be required before EOF can approve the switch. Nevertheless, the wholesale switch from digestive remedies from Rx to OTC is expected occur in Greece towards the end of the forecast period. Under this scenario, expenditure on the promotion of laxatives in the media can be expected to increase significantly. Although demand for laxatives overall is expected to remain static, OTC laxatives value sales would see dramatic growth following such a major switch.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Greece - Category Analysis

TRENDS

  • There was no OTC ear care present in Greece during 2011. All ear care products in the country remain under Rx status, although it should be noted that the majority of Rx ear care products can still be purchased under the counter without a prescription in the majority of Greek chemists/pharmacies.

Eye Care in Greece - Category Analysis

HEADLINES

TRENDS

  • The list of non-reimbursable OTC drugs which was published in May 2010 by the Greek Ministry of Public Health included the majority of standard eye care products, ending the reimbursement of the cost of these products by the Greek State. This naturally led value sales of eye care to decline significantly during 2011. While the declines recorded in value sales of eye care during 2010 reached 30% following the government action in May 2010, the category recovered somewhat during the second half of 2011, increasing in value by around 3% per month, although overall value declines in 2011 were still higher than in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratories Hellas Commercial & Industrial SA continued to lead eye care in Greece during 2011 with a retail value share of 44%. The company has been able to maintain this favourable position in the category as it faces little competition. Alvia SA ranked second in eye care in 2011 with a retail value share of 18%. The star brand in Alcon Laboratories’ eye care product range is Tears Naturale, which consisting of two products: Tears Naturale Free and Tears Naturale II. Tears Naturale remained the leading brand in standard eye care in Greece in 2011 with retail value share of 39%.

PROSPECTS

  • Overexposure to television and computer screens, air conditioning and the pollutants which are prevalent tin urban environments are all becoming common features of everyday life in Greece. As a result, minor eye conditions such as dryness and redness are expected to become more prevalent during the forecast period. This fact and the willingness of Greek consumers to self-medicate are set to combine to ensure that eye care will be able to maintain a relatively stable performance in Greece during the forecast period, in spite of the general economic downturn expected in the country.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2006-2011
  • Table 48 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 49 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 50 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 51 Eye Care Company Shares by Value 2007-2011
  • Table 52 Eye Care Brand Shares by Value 2008-2011
  • Table 53 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Greece - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products in Greece is a consumer health category which seems to be caught between two opposing developments. On the one hand, the current health and wellness trend, which is evident across a wide range of fmcg industries including packaged food and non-alcoholic drinks, continues to benefit herbal/traditional health products. Herbal/traditional products are seen as a safer and more natural way of treating minor illnesses. On the other hand, the grim economic situation in Greece and, more specifically, rapidly shrinking disposable incomes represent a barrier to herbal/traditional products achieving higher growth.

COMPETITIVE LANDSCAPE

  • Cadbury Hellas continued to lead herbal/traditional products in Greece during 2011, claiming a 22% value share. The entirety of this value share was derived from the company’s activity in herbal/traditional cough, cold and allergy (hay fever) remedies through its brands Halls and Halls Vita C. The products sold under the Halls umbrella brand also claimed a substantial proportion of value sales in medicated confectionery in 2011. Medicated confectionery is a category which records high value sales and can be regarded as the most commercialised category within consumer health in Greece as many of the products within the category are available through grocery retail outlets and kiosks.

PROSPECTS

  • Although Greece still lags behind the rest of Europe in terms of the consumer preference for herbal/traditional products with per capita volume and value sales well below the European average, the health and wellness trend is by now well rooted in the collective conscience of Greek consumers and the trend towards seeking out more natural, traditional and herbal alternatives to standard consumer health products is well entrenched. Therefore, demand for herbal/traditional products is expected to continue increasing in Greece over the forecast period. However, it is possible that growth in herbal/traditional products could be hindered by the further deterioration of the Greek economy and shrinking disposable income levels. Developments in the category are not expected to be as rapid as previously projected, although gradual continuous constant growth is nonetheless still anticipated to develop during the forecast period.

CATEGORY DATA

  • Table 55 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 57 Herbal/Traditional Products Company Shares 2007-2011
  • Table 58 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Greece - Category Analysis

HEADLINES

TRENDS

  • There were no significant developments in medicated skin care in Greece during 2011. The lack of innovation resulted in declining value sales against the background of severe economic recession and shrinking disposable incomes. Financially distressed Greek consumers have become increasingly budget-conscious and many Greek people have made attempts to reduce expenditure wherever possible. For many, the purchase of many medicated skin care products began is now regarded as unnecessary and in many cases manufacturers have responded by engaging in price discounts and special offers, and this contributed to the value sales decline recorded in the category during 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson Hellas SA continued to lead medicated skin care in Greece during 2011 with a retail value share of 38%. The company’s strong position in medicated skin care was due mainly to the strength of its global brands such as Regaine in hair loss treatments and Johnson’s Baby and Penaten in nappy (diaper) rash treatments. The company also leads in medicated shampoo with the Fungoral brand.

PROSPECTS

  • No dramatic developments are expected in medicated skin care in Greece during the forecast period. The category is expected to continue declining in constant value during 2012, with a certain degree of stability expected thereafter. Medicated skin care is thus expected to decline in constant value by 2% over the course of the entire forecast period, with growth varying among the various different product categories. Another future trend, mostly notable in antiparasitics/lice (head and body) treatments , is a slow but steady shift towards herbal/traditional products as the forecast period progresses.

CATEGORY DATA

  • Table 61 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 63 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 64 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 65 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 66 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 67 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Greece - Category Analysis

HEADLINES

TRENDS

  • 2011 was the first year during which Greece recorded a significant decline in its smoking population, which, according to domestic surveys, ranges from 4% to as high as 9% of the country’s population. The Greek government recently implemented a public smoking ban, first with a partial ban in July 2009 and then with a complete ban in September 2010. However, this has generally considered to have been a failure as lax enforcement means that few Greek smokers have been forced to adopt a change in their smoking habits. Nevertheless, it seems that Greek smokers are progressively realising the importance of giving up smoking. This is demonstrated by the fact that the number of smokers in Greece visiting smoking cessation centres is rapidly increasing. The high price of cigarettes has proved to be an excellent motivation for Greek people to give up smoking, especially at a time of rapid economic decline, and this is believed to be the main reason for the high numbers of Greek people giving up smoking. According to a recent survey, more than 65% of Greek people have stated that they do not smoke when going out, while 70% see the smoking ban as a positive development.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag Pharmaceutical SACI remained the dominant player in NRT smoking cessation aids in Greece during 2011 with a 98% value share. Its brand Nicorette remained the dominant brand throughout the entire review period as it is the only NRT smoking cessation brand which enjoys widespread distribution and a high level of awareness among Greek consumers.

PROSPECTS

  • The Greek government, in line with EU directives, has set the goal of decreasing smoking rates in the country. This is being attempted through the implementation of tighter regulations, including the implementation of the full public smoking ban in 2010, as well as price increases on tobacco products. The unit prices of tobacco prices were subject to significant increases during 2010 and its ahs been announced that these price increases will continue during the forecast period. While Greece’s strong smoking culture and the tendency for Greeks to sidestep unpopular laws are undermining these legislative efforts, smoking rates in Greece are declining for the first time, and this process is expected to continue throughout the forecast period.

CATEGORY INDICATORS

  • Table 68 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 69 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 70 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 71 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 72 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 73 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 75 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Greece - Category Analysis

HEADLINES

TRENDS

  • In general, sports nutrition in Greece can be accurately described as a niche category of expensive products which are aimed primarily at athletes, bodybuilders and sportspeople and others for whom optimum athletic performance is a priority. Sports nutrition products are widely regarded as solely physical performance enhancing products in Greece. However, certain protein products which can be used for other purposes such as weight control aim to appeal to a broader audience which includes ordinary fitness enthusiasts who exercise on a daily basis. The number of Greek people within this group is expanding.

COMPETITIVE LANDSCAPE

  • Twinlab Corp remained the leading company in sports nutrition in Greece during 2011, claiming a value share of 18%. However, Twinlab was only slightly ahead of second-placed Universal Nutrition with a value share of 17%. Both companies are global players which offer a wide variety of sports nutrition products and in Greece the products of both companies are distributed predominantly through gymnasia and specialist sports equipment stores. It is worth noting that fourth-placed Iso Plus registered a significant increase in its value share in sports nutrition in Greece during 2011, rising by three percentage points to 15% due to the favourable performance of its Solgar Whey-To-Go Protein brand, which is available in chemists/pharmacies outlets throughout Greece.

PROSPECTS

  • Greece’s current adverse economic situation is rather unfavourable for the development of sports nutrition products. Being a category of expensive products which are by no means essential, sports nutrition is being squeezed by shrinking disposable incomes, while at the same time the current health and wellness trend does not favour a category of products which are widely considered as being suitable only for bodybuilders and serious athletes. This situation has not escaped the notice of the category’s leading manufacturers, many of which have increasingly begun to focus their attention on catering to ordinary Greeks who are interested in the health and wellness trend, rather than solely the bodybuilding fraternity and serious athletes. By concentrating more on the potential health benefits of their products, Greece’s sports nutrition manufacturers hope to target a more mainstream audience, which would allow them to begin shifting the image of their products away from the current focus on them being merely muscle-building products towards a situation whereby they are recognised as being beneficial for one’s health and wellness generally.

CATEGORY DATA

  • Table 76 Sales of Sports Nutrition: Value 2006-2011
  • Table 77 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 78 Sports Nutrition Company Shares 2007-2011
  • Table 79 Sports Nutrition Brand Shares 2008-2011
  • Table 80 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 81 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Greece - Category Analysis

HEADLINES

TRENDS

  • Despite a number of unfavourable background factors such as Greece’s deep economic recession, shrinking disposable incomes and widespread price discounting and price reductions, vitamins and dietary supplements in Greece managed positive value growth in 2011. The category displayed a degree of resilience to the economic crisis with demand boosted by the ongoing health and wellness trend. The launch of new products such as Krill Omega 3 and certain probiotic variants, the discovery of the beneficial properties of vitamin D3 and the increasing appeal of combination dietary supplements which are normally associated with health and beauty were among the basic reasons for the ongoing positive development of the category in spite of the grim economic situation in Greece.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Despite declining value sales due to intense competition, Power Health Hellas maintained its leading position in vitamins and dietary supplements in Greece during 2011 with a value share of 12%. The success of Power Health Hellas is largely due to its focus on frequent product development and innovation as well as the wide variety and diversity of its products. Power Health’s new product launches are rapidly brought to the attention of Greek consumers through heavy advertising campaigns, especially in the form of in-store advertising such as posters and window displays in chemists/pharmacies. Sarantis SA followed closely in second position with an 11% value share, mainly due to its popular Lanes brand.

PROSPECTS

  • The future legal status of vitamins and dietary supplements remains set to be the key issue for the category in Greece during the forecast period. While the National Organisation for medicines (EOF) had stated that all herbal products should have a medical file by April 2011 so as to be included in the official OTC list, this has not happened yet and it is uncertain when the situation will actually change. Once certain herbs attain OTC status, including St John’s wort, valeriana, echinacea, sena, agnus castus and milk thistle, it is likely that many current dietary supplements brands will be withdrawn from sale in Greece due to the high cost associated with OTC filing and registration, while those that survive the switch will benefit from rising demand as Greek doctors will be even more willing than previously to recommend dietary supplements with OTC status.

CATEGORY DATA

  • Table 82 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 84 Dietary Supplements by Positioning 2006-2011
  • Table 85 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 86 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 87 Vitamins Brand Shares by Value 2008-2011
  • Table 88 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 17 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Greece - Category Analysis

HEADLINES

TRENDS

  • During 2011, weight management in Greece saw the continuation of the shift away from meal replacement slimming towards weight loss supplements and OTC obesity. Dynamic new product launches within weight loss supplements and the positive performance of GlaxoSmithKline’s Alli—the only brand available in OTC obesity in Greece—were the main reasons for the shift towards weight loss supplements and OTC obesity respectively. These new launches in weight loss supplements and the Alli OTC obesity brand are all backed by extensive advertising campaigns, and this continued to attract consumers to these categories during 2-11. Many overweight Greek people are keener to self-medicate and take the advice of pharmacists than pay for costly visits to doctors and dieticians as their disposable incomes continue to decline. Moreover, the decline seen in meal replacement slimming is largely the result of the poor long-term strategies of the majority of companies which are active in weight management, many of which pursue short-term profits with no real long-term sustainability plan.

COMPETITIVE LANDSCAPE

  • Prevent Hellas remained the leading company in weight management in Greece in 2011 in terms of value sales with a 30% value share. Herbalife International Greece ranked second with a 26% share, whilst Forever Living Products International ranked third with 12%. All of these companies are present within meal replacement slimming. The decline of meal replacement slimming, however, is likely to become a major concern for all of these companies and all three are expected to turn their attention towards weight loss supplements over the forecast period in order to retain their leading value shares.

PROSPECTS

  • The strong shift towards self-medication in Greece is due to shrinking disposable incomes, a situation which is leading to many Greek consumers shifting away from consulting doctors and dieticians about their weight problems and moving towards self-medication on the advice of pharmacists. This suggests that chemists/pharmacies is the retail distribution channel in which competition for the distribution of weight management products is set to be most intense during the forecast period. The shift within weight management away from meal replacement products towards weight loss supplements is expected to gather pace in Greece over the forecast period. In addition, competition to meal replacement slimming will also come from OTC obesity, specifically GlaxoSmithKline’s Alli brand. Competition from outside weight management will also come from the increasing number of fortified packaged food products aimed at Greek people who are concerned about their weight such as fortified breakfast cereals and a wide variety of low fat packaged food products.

CATEGORY DATA

  • Table 91 Sales of Weight Management: Value 2006-2011
  • Table 92 Sales of Weight Management: % Value Growth 2006-2011
  • Table 93 Weight Management Company Shares 2007-2011
  • Table 94 Weight Management Brand Shares 2008-2011
  • Table 95 Forecast Sales of Weight Management: Value 2011-2016
  • Table 96 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Greece - Category Analysis

HEADLINES

TRENDS

  • The most prominent trend in wound care in Greece during 2011 was the ongoing decline of the category as negative value growth was recorded for the second consecutive year as a result of the general decline of the Greek economy. Moreover, value sales of private label wound care declined during 2011 following the positive growth recorded during 2010. The shift towards private label wound care and economy wound care variants in 2010 was largely due to a high degree of trial purchases and Greek consumers returned to value-added branded wound care products in 2011 as the quality of cheaper wound care variants proved to be highly disappointing. At the same time, a very different trend is also developing in wound care in Greece: increasing product specialisation. This is occurring as Greek consumers tend to choose the appropriate wound care product for specific occasions with products such as children’s sticking plasters and specialised wound care products especially for the treatment of burns. Specialised, innovative products such as Hansaplast Invisible Protection were launched during 2010, and the majority of these met with enduring success during 2011.

COMPETITIVE LANDSCAPE

  • Beiersdorf Hellas SA continued to lead wound care in Greece during 2011 as its retail value share increased to 65%. Beiersdorf Hellas SA is the manufacturer of the popular Hansaplast brand, which offers various wound care product lines ranging from sticking plasters to wound care in spray format, all of which have developed high brand awareness and significant brand loyalty among Greek consumers. Hansaplast’s long-standing presence in Greece has led to the situation whereby the Hansaplast brand name is now commonly used as a generic term for sticking plasters in Greece.

PROSPECTS

  • Wound care in Greece can be regarded as a rather mature category and, as such, there is little or no room left for ongoing growth or expansion over and above the expansion of specific product lines. Over the forecast period, wound care is expected to register negative constant value growth, declining at a CAGR of -5% in an echo of the negative course which the Greek economy is expected to take. While private label wound care products did not manage to achieve an increase in value share during 2011, more intensive price promotions are set to occur, contributing to the value decline expected in wound care during the forecast period. At the same time, the higher quality and more innovative features of branded wound care variants which offer better value for money ensure that a significant proportion of the consumer base for wound care will either return to or continue using branded wound care such as Hansaplast.

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2006-2011
  • Table 98 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 99 Wound Care Company Shares by Value 2007-2011
  • Table 100 Wound Care Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Spirulina
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Yeast
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!